Sunway Medical Centre Velocity (SMCV) revolutionise patient care with its state-of-the-art robotic surgery services, featuring the sophisticated, da Vinci Xi and Mako SmartRobotics surgical systems. This technological advancement further underscores SMCV’s commitment to providing cutting-edge medical procedures, enhancing patient outcomes, and elevating healthcare standards for the local community.
These robotic-assisted surgical systems represent a quantum leap in surgical technology, empowering surgeons to perform a wide range of minimally invasive procedures with exceptional precision, control and dexterity beyond the capabilities of a normal human hand.
Robotic surgery, a rapidly growing field within the healthcare industry, leverages robotic systems to assist in surgical procedures, offering a minimally invasive alternative to traditional laparoscopic surgery. The da Vinci Xi surgical system amplifies the capabilities and versatility of robotic-assisted surgeries, delivering greater precision, enhanced vision and improved access to the surgical site.
Meanwhile, the Mako SmartRobotics system provides precise and customised operations based on patient-specific plan created by its 3D imaging, allowing the technology to accurately reproduces the natural kinematics of the knee, restoring alignment and enhancing joint performance.
These technological marvels are set to redefine the surgical landscape in Malaysia, covering various specialties, including and not limited to urology, gynaecology, bariatric surgery, colorectal surgery, general surgery, or ear, nose, throat (ENT) surgery for the da Vinci Xi surgical system and orthopaedic surgery for the Mako SmartRobotics surgical system, allowing surgeons the ability to conduct complex procedures with enhanced control and flexibility.
The da Vinci Xi system’s high-definition 3D visualisation enhances precision and decision-making during surgery, resulting in smaller incisions, reduced blood loss and quicker recovery for patients. Dato’ Dr Selvalingam Sothilingam, Consultant Urologist from SMCV emphasises the transformative impact, “The versatility of the da Vinci Xi surgical system is a game-changer in the field of medicine, offering precision and improved patient outcomes.”
On the other hand, Mako SmartRobotics system provides a less invasive surgery, leading to reduced pain levels and also lesser recovery time for patients, adding that the robotic arm ensures precise placement of component, reducing the risk of implant failure, complications and the need for future surgeries.
Making Advanced Medical Services Accessible with Robotic4U Fund
Additionally, SMCV has been spearheading the Robotic4U Fund since 2024 — an initiative designed to provide eligible patients from all backgrounds, including those from low-income groups, self-paying patients and individuals with limited insurance coverage, the opportunity to undergo robotic surgery at a subsidised cost. The initiative is applicable to participating surgeons across various medical specialties offering robotic surgery as a treatment option and will be available until 31st December 2025.
Ms Susan Cheow, Chief Executive Officer (CEO) of SMCV, expresses her enthusiasm, stating, “Since the introduction of our Robotic Surgery Service in last year, together with the establishment of the Robotic4U Fund, SMCV has made significant strides towards our vision of providing advanced healthcare solutions that are accessible to all. We believe that cost should not be a barrier to healthcare, as every patient deserves the right to a better quality of life. This initiative continues to redefine patient care in Malaysia, ensuring that cutting-edge medical treatments are within reach for everyone.”
